Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans, Stier H., Vos E., Kenley D., Journal (Journal of Endocrinology and Metabolism, Volume 3, Issues 12, 2013, Pages 715)
No company currently has clear profit motive to spend millions funding human trials
Read Is Peptide Therapy the Same as Hormone Therapy in Charleston, SC
Like all peptides, it's vulnerable to enzymatic degradation when exposed to the gastrointestinal (GI) tract
Published pharmacokinetic work describes a plasma half-life of only a few minutes after intravenous administration
The Velora TB-500 fragment is approximately 889 daltons (per Velora product-page specifications for their fragment